XS Financial Provides $7.6 Million CAPEX Financing to PharmaCann Inc.

Rhea-AI Summary

XS Financial Inc. has entered into a new lease agreement worth $7.6 million with PharmaCann Inc. The lease will support PharmaCann's growth plans in its eight-state footprint. This transaction demonstrates XS Financial's commitment to the cannabis industry and its dedication to supporting top-tier operators.

LOS ANGELES, CA / ACCESSWIRE / August 7, 2023 / XS Financial Inc. ("XS Financial", "XSF" or the "Company") (CSE:XSF)(OTCQB:XSHLF), a specialty finance company providing CAPEX and equipment financing solutions to cannabis companies in the United States, announced today that it has entered into a new lease with PharmaCann Inc ("PharmaCann"), for $7.6 million. All amounts are in U.S. dollars.

PharmaCann continues to deploy resources from its pre-existing $30 million facility, announced on December 11, 2022, leveraging available capital to further drive growth within its business.

Patrick Unzicker, CFO of PharmaCann commented: "We highly value our long-term relationship with XS Financial as a financing partner for our strategic capital needs. This transaction provides funding to support PharmaCann growth plans in our eight state foot print."

Antony Radbod, COO of XS Financial commented: "We are thrilled to announce the successful closing of a new lease transaction with our esteemed, long-standing client, Pharmacann. This latest round of financing is a testament to XS Financials' commitment to the cannabis industry and reaffirms our steadfast dedication to the broader market. Amid the current capital-constrained climate, this transaction underscores our unwavering commitment to supporting top-tier operators in the cannabis industry."

About PharmaCann

PharmaCann Inc. is one of the nation's largest privately held, vertically integrated cannabis companies, providing safe, reliable, and high-quality cannabis products to people in both the medical and adult-use markets. The PharmaCann geographic footprint includes dispensaries and cultivation and processing operations in eight states. For more information about PharmaCann, please visit Pharmacann.com.

About XS Financial

Founded in 2017, XS Financial specializes in providing CAPEX financing solutions to cannabis companies in the United States, including cultivators, processors, manufacturers, and testing laboratories. In addition, XSF has partnered with over 250 original equipment manufacturers (OEM) through its network of Preferred Vendor partnerships. This powerful dynamic provides an end-to-end solution for customers which results in recurring revenues, strong profit margins, and a proven business model for XSF stakeholders. The Company's subordinate voting shares are traded on the Canadian Securities Exchange under the symbol "XSF". For more information, visit: www.xsfinancial.com.

For inquiries please contact:

David Kivitz Chief Executive Officer	Antony Radbod Chief Operating Officer
Tel: 1-310-683-2336
Email: ir@xsfinancial.com

Forward-Looking Information

This press release contains "forward-looking information" and may also contain statements that may constitute "forward-looking statements", collectively "forward-looking information", within the meaning of applicable Canadian securities legislation. Such forward-looking information is not representative of historical facts or information or current condition, but instead represent the beliefs and expectations regarding future events about the business and the industry and markets in which XS Financial operates, as well as plans or objectives of management, many of which, by their nature, are inherently uncertain. Generally, such forward-looking information can be identified by the use of terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or may contain statements that certain actions, events or results "may", "could", "would", "might" or "will be taken", "will continue", "will occur" or "will be achieved". Forward-looking information contained herein may include but is not limited to, any additional leasing opportunities and the ability to capitalize on such and the timing thereof. Forward-looking information is not a guarantee of future performance and involve risks, uncertainties and assumptions which are difficult to predict. Accordingly, readers should not place undue reliance on forward-looking information, which are qualified in their entirety by this cautionary statement. XS Financial Inc., does not undertake any obligation to release publicly any revisions for updating any voluntary forward-looking information, except as required by applicable securities law.

Neither the Canadian Securities Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

SOURCE: XS Financial

View source version on accesswire.com:
https://www.accesswire.com/772544/XS-Financial-Provides-76-Million-CAPEX-Financing-to-PharmaCann-Inc

FAQ

What is the name of the company mentioned in the press release?

The company mentioned in the press release is XS Financial Inc.

What is the value of the new lease agreement?

The new lease agreement is worth $7.6 million.

Which company has entered into the lease agreement with XS Financial?

PharmaCann Inc. has entered into the lease agreement with XS Financial.

What is the purpose of the lease agreement?

The lease agreement will support PharmaCann's growth plans in its eight-state footprint.

What does XS Financial's commitment to the cannabis industry signify?

XS Financial's commitment to the cannabis industry demonstrates its dedication to supporting top-tier operators.